Characteristics and prognosis study of real-world cardiac amyloidosis

Characteristics and prognosis study of real-world cardiac amyloidosis - CAPTURE-AMYLOID

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038307

Enrollment

100

Registered

2019-11-01

Start date

2019-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac amyloidosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who were diagnosed as cardiac amyloidosis after September 1, 2019 2. Patients in whom written informed consent was obtained

Exclusion criteria

Exclusion criteria: Patients in whom written informed consent was not obtained

Design outcomes

Primary

Measure	Time frame
A composite of all-cause death and hospitalization for heart failure	—

Countries

Japan

Contacts

Public ContactRyusuke Nishikawa

Kyoto University Hospital Department of Cardiovascular Medicine

rn6072@kuhp.kyoto-u.ac.jp075-751-4255

Outcome results